Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Device Reclassifications Are Burdensome, Trade Groups Say

This article was originally published in The Gray Sheet

Executive Summary

Comments from AdvaMed and its European counterpart Eucomed raise concerns about device reclassifications appearing in the revised Medical Devices Directive

You may also be interested in...



Combo Products Face Costlier Process Under Europe’s New MDD – Alcon Exec

The combination product policy outlined in the proposed revisions to Europe's Medical Devices Directive is emerging as a leading industry concern

Combo Products Face Costlier Process Under Europe’s New MDD – Alcon Exec

The combination product policy outlined in the proposed revisions to Europe's Medical Devices Directive is emerging as a leading industry concern

MDD Revision Clarifies Existing Policies, Tightens Industry Loopholes

A draft revision of the European Medical Devices Directive would give manufacturers of implantable and Class III devices less leeway to avoid clinical evaluation requirements

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel